Repaglinide
- Product NDC
- 60687-560
- 11-digit product format
- 606870560
- Labeler code
- 60687
- Product ID
- 60687-560_2517f71f-f461-1f56-e063-6394a90a6ef1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA203820
- Marketing category
- ANDA
- Marketing start
- 2020-09-17
- Substance
- REPAGLINIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200256 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60687-560-11 | Repaglinide | 1 in 1 BLISTER PACK | TABLET | 1 | | 4 |
| 60687-560-21 | Repaglinide | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60687-560 | REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241024_dd1d8337-9903-4b8a-a9ea-569e4d134e74.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-560-11 | 60687056011 | 1 in 1 BLISTER PACK | | | | | | Historical |
| 60687-560-21 | 60687056021 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11) | 30 blister pack | 2020-09-17 | 0000-00-00 | No | No | Current |